Rebus Holdings Inc (RBSH)

[blanka]

No HYPE this is a REVERSE MERGER

https://phytonbiotech.com/phyton-biotech-achieves-manufacturing-milestone-with-thapsigargin-the-active-agent-in-mipsagargin/

Phyton is converting the Thapsia plant into thapsigargin in partnership with Inspyr Therapeutics, Inc. (OTCQB: NSPX),

a clinical-stage biotechnology company that has a patented technology platform utilizing thapsigargin for its prodrug delivery system, mipsagargin. Yes and the patent is Active recently...

https://patents.google.com/patent/CA2930767A1/en

A possible partnership LOOKS be in the making through Phyton Biotech IMO, they work with a lot of big Pharma players and this company is an expert in the field thanks to their Plant Cell Fermentation Technology.

https://www.pharmacompass.com/speak-pharma/our-pcf-technology-makes-us-have-a-minimal-environmental-footprint-while-ensuring-a-sustainable-supply-of-drugs-speakpharma-with-phyton-biotech

MANY NEED TO KNOW HOW TO LEARN TO CONNECT THE DOTS...

1. WHY GO CURRENT AND SPEND 250K

2. WHY HAVE CURRENT PATENTS NOW ACTIVE?

3. WHY UPDATE THIER WEBSITE?

4.((MOST RECENTLY AS OF April 7th 2020 ) BOTANICAL AND PLANT-DERIVED DRUGS MARKET 2020 | BY TRENDING MANUFACTURERS | BY REGIONS | BY TYPES AND APPLICATIONS, FORECASTS TO 2026

https://germanyenglishnews.com/german-news/2020/04/07/botanical-and-plant-derived-drugs-market-2020-by-trending-manufacturers-by-regions-by-types-and-applications-forecasts-to-2026/

Smells like A Reverse MERGER, a Partnership or BUYOUT is in the works and needs NSPX to be updated with what they have in thier CORE ...